We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Visualizing How Cancer Chromosome Abnormalities Form in Living Cells

By LabMedica International staff writers
Posted on 20 Aug 2013
Scientists have for the first time directly observed events that lead to the formation of a chromosome abnormality that is frequently found in cancer cells. More...
The abnormality, called a translocation, occurs when part of a chromosome breaks off and then binds to another chromosome.

The study’s findings, conducted by scientists at the U.S. National Cancer Institute (NCI; Bethesda, MD, USA), part of the National Institutes of Health, were published August 9, 2013, in the journal Science. 

Chromosome translocations have been found in almost all cancer cells, and it has long been known that translocations can play a role in cancer development. However, spite of intensive of research, just precisely how translocations form in a cell has remained elusive. To better determine this process, the researchers created a research system in which they induced, in a controlled way, breaks in the DNA of different chromosomes in living cells. Using cutting-edge imaging technology, they were then able to see when the broken ends of the chromosomes were reattached correctly or incorrectly inside the cells.

Translocations are very rare occurrences, and the investigators’ ability to visualize these events in real time was made possible bya recently developed technology that is being used at the NCI that enables investigators to visualize alterations in thousands of cells over a long time. “Our ability to see this fundamental process in cancer formation was possible only because of access to revolutionary imaging technology,” said the study’s senior author, Tom Misteli, PhD, Laboratory of Receptor Biology and Gene Expression, Center for Cancer Research, NCI.

The scientists involved with this study were able to demonstrate that translocations can occur within hours of DNA breaks and that their formation is independent of when the breaks happen during the cell division cycle. Cells have intrinsic mending mechanisms that can fix most DNA breaks, but translocations at times still occur.

To additionally examine the role of DNA repair in translocation formation, the researchers curbed vital pieces of the DNA damage response processes within cells and monitored the effects on the repair of DNA breaks and translocation formation. They discovered that suppression of one element of DNA damage response processes, a protein called DNAPK-kinase, increased the occurrence of translocations almost 10-fold. The scientists also determined that translocations formed preferentially between prepositioned genes.

“These observations have allowed us to formulate a time and space framework for elucidating the mechanisms involved in the formation of chromosome translocations,” said Vassilis Roukos, PhD, NCI, and lead scientist of the study. “We can now finally begin to really probe how these fundamental features of cancer cells form.”

Related Links:
US National Cancer Institute


Gold Member
Veterinary Hematology Analyzer
Exigo H400
Serological Pipet Controller
PIPETBOY GENIUS
New
Automatic Hematology Analyzer
LABAS F9000
New
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.